HOLMDEL, N.J., March 27, 2024 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q4 2023 investor call Tuesday, April 2nd at 10 a.m. ET. Results will be released after the market close on Monday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the call and Q&A session.
Conference Call Details
| Date / Time: | Tuesday, April 2nd at 10 a.m. ET |
| Call Dial In #: | 1-877-418-5460 U.S. or 1-412-717-9594 Int’l |
| Live Webcast / Replay: | Webcast & Replay Link – Available for 3 months. |
| Audio Replay: | 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 6114035 |
BIO-key at a Glance
| Recent Price | $2.00 | TTM Revenue | $8.6M | ||
| Shares Out.* | 1.9M | TTM Revenue Growth | +39% | ||
| Market Cap | $3.9M | Price/TTM Revenue | 0.45X |
* Common stock and common stock equivalents outstanding.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over 38 million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
Engage with BIO-key
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
Bay Street News